A randomized controlled safety and acceptability trial of dextrin sulphate vaginal microbicide gel in sexually active women in Uganda

AIDS

Volumn 19, Issue 18, 2005, Pages 2149-2156

  Bakobaki, Julie M ^a,b   Lacey, Charles J ^c,d   Bukenya, Michael I ^a   Nunn, Andrew J ^b   McCormack, Sheena ^b   Byaruhanga, Romano N ^e   Okong, Pius ^e   Namukwaya, Stella W ^a   Grosskurth, Heiner ^a   Whitworth, James A G ^f  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF YORK   (United Kingdom)

^e St Francis Hospital Uganda   (Uganda)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Acceptability studies; Condoms; Dextrin sulphate; Prevention of sexual transmission; Safety studies; Vaginal microbicides

Indexed keywords

DEXTRIN; DEXTRIN SULFATE; PLACEBO; SULFATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANDIDA; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; GEL; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STATISTICAL SIGNIFICANCE; THROMBIN TIME; THROMBOCYTE; TIME; UGANDA; VAGINA BLEEDING; VAGINA FLORA;

EID: 27944438486     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000194129.05264.55     Document Type: Article

References (12)

1. UNAIDS AIDS epidemic update: December 2004. http://www.unaids.org/ NetTools/Misc/DocInfo.aspx?href=http%3A% 2F%2Fgva%2Ddoc%2Dowl%2FWEBcontent%2Fdocuments% 2Fpub%2Fpublications%2FIRC%2Dpub06%2FJC943%2Depi Update2003%5Fen%2Epdf, last accessed 27 March 2005.
2. McCormack S, Hayes R, Lacey C, Johnson A. Science, medicine and the future: microbicides in HIV prevention. BMJ 2001; 322: 410-413.
3. Van Damme L, Rosenberg ZF. Microbicides and barrier methods in HIV prevention. AIDS 1999; 13 (suppl A):S85-S92.
4. Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Microbiology 2003; 1:25-35.
5. Polsky B, Baron PA, Gold JWM, Smith JL, Jensen RH, Armstrong D. In-vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9. Lancet 1988; 1:1456.
6. WHO. WHO/CONRAD Technical Consultation on Nonoxynol-9: Summary Report. Geneva: World Health Organisation; 2003.
7. McClure MO, Moore JP, Blanc DF, Scotting P, Cook GM, Keynes RJ, et al. Investigations into the mechanism by which sulphated polysaccharides inhibit HIV infection in vitro. AIDS Res Hum Retrov 1992; 8:19-22.
8. Low-Beer N, Gabe R, McCormack S, Kitchen VS, Lacey CJ, Nunn AJ. Dextrin sulphate as a vaginal microbicide: randomized, double-blind, placebo-controlled trial including healthy female volunteers and their male partners. J Acquir Immune Defic Syndr 2002; 31:391-398.
9. Rosenstein I, Stafford M, Kitchen V, Ward H, Weber J, Robinson D. Effect on vaginal flora of three intravaginal microbicide agents potentially active against HIV. J Infect Dis 1998; 177: 1386-1390.
10. McCormack S, Jespers V, Low-Beer N, Gabe R, Kaganson N, Chapman N, et al. A dose-ranging Phase I study of dextrin sulphate, a vaginal microbicide, in HIV-negative and HIV-positive female volunteers. Sex Transm Dis (in press).
11. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardised method of gram stain interpretation. J Clin Microbiol 1991; 29: 297-301.
12. Shapley M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. Br J General Pract 2004; 54:359-363.